TONIX PHARMACEUTICALS
Clinical-stage biopharmaceutical company
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 7 of its records are shown together here.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Report 3rd Quarter 2026
|
VALCOUR LLC | $30,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
STRATEGIC MARKETING INNOVATIONS | $40,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
BROYDRICK & ASSOCIATES | $20,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
POLSINELLI PC | $20,000 reported |
|
Registration 3rd Quarter 2026
|
POLSINELLI PC | — reported |
|
3rd Quarter - Termination 3rd Quarter 2026
|
FOLEY HOAG LLP | $20,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
VALCOUR LLC | $30,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
BROYDRICK & ASSOCIATES | $20,000 reported |
|
2nd Quarter - Reportreplaced 2nd Quarter 2026
|
BROYDRICK & ASSOCIATES | $20,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
STRATEGIC MARKETING INNOVATIONS | $40,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| BROYDRICK & ASSOCIATES | 39 | $780,000 |
| CARDINAL POINT PARTNERS | 33 | $670,000 |
| VALCOUR LLC | 15 | $390,000 |
| FOLEY HOAG LLP | 12 | $270,000 |
| STRATEGIC MARKETING INNOVATIONS | 4 | $130,000 |
| THE SHELBURNE GROUP | 23 | $80,000 |
| POLSINELLI PC | 1 | $20,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 64 |
| Pharmacy | PHA | 40 |
| Defense | DEF | 24 |
| Disaster Planning/Emergencies | DIS | 14 |
| Budget/Appropriations | BUD | 14 |
| Veterans | VET | 8 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| S. 3799 | 117th | 4 |
| S. 2333 | 118th | 3 |
| H.R. 8774 | 118th | 3 |
| H.R. 4365 | 118th | 3 |
| H.R. 925 | 117th | 3 |
| H.R. 8236 | 117th | 3 |
| H.R. 4502 | 117th | 3 |
| H.R. 8295 | 117th | 3 |
| S. 3062 | 117th | 3 |
| H.R. 7900 | 117th | 3 |
| H.R. 2968 | 116th | 3 |
| S. 1790 | 116th | 3 |
| S. 785 | 116th | 3 |
| H.R. 2500 | 116th | 3 |
| S. 4942 | 118th | 2 |
| S. 2587 | 118th | 2 |
| H.R. 9029 | 118th | 2 |
| H.R. 8070 | 118th | 2 |
| S. 4921 | 118th | 2 |
| S. 4638 | 118th | 2 |
| H.R. 2617 | 117th | 2 |
| S. 4543 | 117th | 2 |
| H.R. 7614 | 116th | 2 |
| H.R. 7776 | 117th | 1 |
| H.R. 1219 | 117th | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.